What transvaginal ultrasound findings are diagnostic of pregnancy failure in a 32-year-old woman (G3P0) at 7 weeks and 6 days pregnant by Last Menstrual Period (LMP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 14, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transvaginal Ultrasound Findings Diagnostic of Pregnancy Failure

The correct answer is (d): Absence of embryo with heartbeat ≥11 days after a scan that showed a gestational sac with a yolk sac is definitively diagnostic of pregnancy failure. 1

Definitive Diagnostic Criteria for Pregnancy Failure

The following transvaginal ultrasound findings are definitively diagnostic of pregnancy failure and do not require follow-up imaging:

Crown-Rump Length Criteria

  • CRL ≥7 mm without cardiac activity is diagnostic of embryonic demise 1, 2
  • Option (a) with CRL of 5 mm and no heart rate does NOT meet diagnostic criteria and requires follow-up imaging in 7-10 days 1

Mean Sac Diameter Criteria

  • MSD ≥25 mm without an embryo is diagnostic of pregnancy failure 1
  • Option (b) with MSD of 20 mm does NOT meet diagnostic criteria—this is below the threshold and requires follow-up ultrasound 1

Time-Based Criteria with Yolk Sac

  • Absence of embryo with cardiac activity ≥11 days after visualization of gestational sac WITH yolk sac is diagnostic of pregnancy failure 1
  • This is option (d) and represents the correct answer

Time-Based Criteria without Yolk Sac

  • Absence of embryo with cardiac activity ≥14 days after visualization of gestational sac WITHOUT yolk sac is diagnostic of pregnancy failure 1
  • Option (c) states >10 days, which does NOT meet the required ≥14 day threshold 1

Why Each Answer is Correct or Incorrect

Option (a) - INCORRECT: A CRL of 5 mm without cardiac activity is concerning but not diagnostic. The definitive threshold is CRL ≥7 mm. 1, 2 At 5 mm, follow-up imaging should be performed rather than making a definitive diagnosis of pregnancy failure. 1

Option (b) - INCORRECT: An MSD of 20 mm without an embryo falls into the "concerning" category (16-24 mm range) but does not meet the ≥25 mm threshold required for definitive diagnosis. 1 This requires follow-up ultrasound in 7-10 days. 1

Option (c) - INCORRECT: The timeframe of >10 days is insufficient. The guideline requires ≥14 days after visualization of a gestational sac without a yolk sac to diagnose pregnancy failure definitively. 1

Option (d) - CORRECT: This meets the Society of Radiologists in Ultrasound consensus criteria requiring ≥11 days after visualization of a gestational sac with a yolk sac. 1 The presence of a yolk sac indicates more advanced development, hence the shorter required interval (11 days vs 14 days without yolk sac).

Critical Clinical Context

At 7 weeks 6 days gestation by LMP:

  • Cardiac activity should be reliably visible by transvaginal ultrasound in a viable pregnancy 2
  • Any measurable embryo should demonstrate cardiac activity 1, 2
  • The discriminatory hCG level (approximately 3,000 mIU/mL) should be exceeded, making a gestational sac clearly visible 3

Essential Pitfalls to Avoid

  • Never diagnose pregnancy failure on a single measurement without confirming absence of cardiac activity 1
  • Ensure adequate time intervals between measurements before concluding abnormal growth 1
  • Use transvaginal rather than transabdominal ultrasound for accurate first-trimester assessment 1
  • Document exact measurements of CRL and MSD to avoid diagnostic errors 1
  • Confirm gestational age by LMP to avoid dating errors that could lead to misdiagnosis 1

References

Guideline

Crown-Rump Length Measurements for Gestational Age Dating

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cardiac Activity Detection by Transvaginal Ultrasound

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

hCG and Progesterone Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What transvaginal ultrasound findings are diagnostic of pregnancy failure in a 32-year-old woman (G3P0) at 7 weeks and 6 days gestation by Last Menstrual Period (LMP)?
What is the next step in management for a pregnant patient with a gestational sac and yolk sac on ultrasound, but no visible fetal pole or heartbeat, and significantly elevated human chorionic gonadotropin (hCG) levels?
What is the further management and investigation for a 33-year-old patient with a positive urine pregnancy test (UPT), 7 weeks of amenorrhea, thick endometrium (16mm), and a <1cm adrenal cystic lesion with mild vascularity, suspected to be a corpus luteal cyst, on ultrasound (USG)?
What should be done if two home pregnancy tests (Human Chorionic Gonadotropin (hCG) tests) are negative but pregnancy is still suspected?
What type of ultrasound, transvaginal (TV) or abdominal, is recommended at 8.5 weeks of pregnancy?
What is the recommended initial diagnostic imaging study for a postpartum patient presenting with symptoms suggestive of pulmonary embolism, including moderate dyspnea and tachycardia?
Which anti-tuberculosis treatments (ATT) most commonly cause gastritis?
What is the diagnostic approach and treatment for a patient suspected of having thyrotoxic heart disease with potential hyperthyroidism and cardiac dysfunction?
Is it normal for a young to middle-aged adult with a history of cannabis (marijuana) use to experience persistent gastrointestinal symptoms, including abnormal bowel movements, 2 months after cessation of use?
What are the components and interpretations of the Eastern Cooperative Oncology Group (ECOG) performance status scale and the Karnofsky Performance Status (KPS) scale in assessing a patient's ability to perform daily activities and tolerate cancer treatment, particularly for a patient with advanced cancer and good performance status?
How often should TSH (Thyroid-Stimulating Hormone) levels be monitored in a patient with Graves' disease after adjusting their methimazole dosage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.